Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single room-based configuration of its HyperVue Imaging System for DeepOCT+NIRS ...
Optical Coherence Tomography (OCT)
Optical coherence tomography (OCT) is an catheter-based intravascular imaging technology that uses low-coherence light interferometry, using near-infrared light, to capture high-resolution 2-D and 3-D image reconstructions of coronary arteries. It has a lower level of tissue penetration than intravascular ultrasound (IVUS), but offers much higher resolution images of the tissues. It is used to determine the nature and extent of the atheroscleratic disease in the vessel wall, to assess in-stent restenosis and aid catheter procedure navigation in the cath lab.
-
-
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand the presence of its Novasight Hybrid System in the U.S. market in 2022 under ... -
December 15, 2021 — Conavi Medical Inc. has entered into agreements for over $20 million in funding to support commercialization and growth as it prepares its innovative Novasight Hybrid System for ...
-
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence tomography (OCT) imaging platform powered by the company's new Ultreon Software. It ...
Nov. 2, 2026 — Royal Philips has announced U.S. commercial availability of the HyperVue Integrated System1, a new single ...
November 03, 2026
Nov. 2, 2026 – Conavi Medical Corp. has announced the completion of the first U.S. placement and clinical cases with ...
November 03, 2026
Sept. 17, 2026 — Conavi Medical Corp. has announced the publication of a peer-reviewed case report highlighting the ...
September 22, 2026
July 8, 2026 — Conavi Medical Corp. has announced the publication of a case report in the Journal of the Society for ...
July 15, 2026
April 20, 2026 — Conavi Medical Corp. recently announced that it has received U.S. Food and Drug Administration (FDA) ...
April 22, 2026
Feb. 13, 2026 — Conavi Medical Corp. recently highlighted the publication of new peer-reviewed research titled “Deep ...
February 16, 2026
August 29, 2023 — Optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding ...
August 29, 2023
August 29, 2023 — Abbott announced late-breaking data from the first-of-its-kind ILUMIEN IV OPTIMAL PCI (ILUMIEN IV) ...
August 29, 2023
Conavi Medical Inc., a leader of hybrid imaging guidance for common minimally invasive heart procedures, plans to expand ...
February 16, 2022
December 15, 2021 — Conavi Medical Inc. has entered into agreements for over $20 million in funding to support ...
December 15, 2021
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence ...
August 05, 2021
May 12, 2021 — Abbott recently announced its new interventional imaging platform powered by Ultreon 1.0 Software, has ...
May 12, 2021
February 16, 2021 – SpectraWave Inc. announced a $13.2 million series A-2 financing to support completion of product ...
February 16, 2021
November 17, 2020 — Diagnostic imaging techniques were able to find the underlying cause of heart attack in many women ...
November 17, 2020
Feature | FFR Technologies | Dave Fornell, Editor
Fractional flow reserve (FFR) is considered the gold standard measure whether a coronary lesions needs a percutaneous ...
October 30, 2020